Some new drugs aren’t actually ‘new’ – pharmaceutical companies exploit patents and raise prices for patients, but data transparency can help protect innovation

Pharmaceutical innovation saves lives. But not every “new” drug is truly new. Patents are designed to reward breakthrough inventions by granting the inventors temporary monopoly rights to recoup the costs…

Challenging the FDA’s authority isn’t new – the agency’s history shows what’s at stake when drug regulation is in limbo

Political pressure is nothing new for the U.S. Food and Drug Administration. The agency has frequently come under fire for its drug approval decisions, but attacks on its decision-making process…